Literature DB >> 18606667

Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis.

Rie Kajino-Sakamoto1, Maiko Inagaki, Elisabeth Lippert, Shizuo Akira, Sylvie Robine, Kunihiro Matsumoto, Christian Jobin, Jun Ninomiya-Tsuji.   

Abstract

Recent studies have revealed that TAK1 kinase is an essential intermediate in several innate immune signaling pathways. In this study, we investigated the role of TAK1 signaling in maintaining intestinal homeostasis by generating enterocyte-specific constitutive and inducible gene-deleted TAK1 mice. We found that enterocyte-specific constitutive TAK1-deleted mice spontaneously developed intestinal inflammation as observed by histological analysis and enhanced expression of IL-1beta, MIP-2, and IL-6 around the time of birth, which was accompanied by significant enterocyte apoptosis. When TAK1 was deleted in the intestinal epithelium of 4-wk-old mice using an inducible knockout system, enterocytes underwent apoptosis and intestinal inflammation developed within 2-3 days following the initiation of gene deletion. We found that enterocyte apoptosis and intestinal inflammation were strongly attenuated when enterocyte-specific constitutive TAK1-deleted mice were crossed to TNF receptor 1(-/-) mice. However, these mice later (>14 days) developed ileitis and colitis. Thus, TAK1 signaling in enterocytes is essential for preventing TNF-dependent epithelium apoptosis and the TNF-independent development of ileitis and colitis. We propose that aberration in TAK1 signaling might disrupt intestinal homeostasis and favor the development of inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606667      PMCID: PMC3065656          DOI: 10.4049/jimmunol.181.2.1143

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.

Authors:  Arianna Nenci; Marion Huth; Alfred Funteh; Marc Schmidt-Supprian; Wilhelm Bloch; Daniel Metzger; Pierre Chambon; Klaus Rajewsky; Thomas Krieg; Ingo Haase; Manolis Pasparakis
Journal:  Hum Mol Genet       Date:  2006-01-06       Impact factor: 6.150

Review 2.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

Review 3.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

4.  Essential function for the kinase TAK1 in innate and adaptive immune responses.

Authors:  Shintaro Sato; Hideki Sanjo; Kiyoshi Takeda; Jun Ninomiya-Tsuji; Masahiro Yamamoto; Taro Kawai; Kunihiro Matsumoto; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-09-25       Impact factor: 25.606

5.  The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF.

Authors:  T Ishitani; J Ninomiya-Tsuji; S Nagai; M Nishita; M Meneghini; N Barker; M Waterman; B Bowerman; H Clevers; H Shibuya; K Matsumoto
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

Review 6.  The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease.

Authors:  S Papa; C Bubici; F Zazzeroni; C G Pham; C Kuntzen; J R Knabb; K Dean; G Franzoso
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

7.  Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation.

Authors:  Fang Yan; Sutha K John; Guinn Wilson; David S Jones; M Kay Washington; D Brent Polk
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

8.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

Authors:  Jae-Hyuck Shim; Changchun Xiao; Amber E Paschal; Shannon T Bailey; Ping Rao; Matthew S Hayden; Ki-Young Lee; Crystal Bussey; Michael Steckel; Nobuyuki Tanaka; Gen Yamada; Shizuo Akira; Kunihiro Matsumoto; Sankar Ghosh
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

9.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  The TGF beta activated kinase TAK1 regulates vascular development in vivo.

Authors:  Joy L Jadrich; Michael B O'Connor; Electra Coucouvanis
Journal:  Development       Date:  2006-04       Impact factor: 6.868

View more
  78 in total

Review 1.  Innate immune signaling in defense against intestinal microbes.

Authors:  Melissa A Kinnebrew; Eric G Pamer
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.

Authors:  Harald Renz; Per Brandtzaeg; Mathias Hornef
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

3.  Between vigilance and tolerance: the immune function of the intestinal epithelium.

Authors:  Cécilia Chassin; Mathias W Hornef
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

Review 4.  Establishment of intestinal homeostasis during the neonatal period.

Authors:  Silvia Stockinger; Mathias W Hornef; Cécilia Chassin
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

Review 5.  Targeting innate immunity protein kinase signalling in inflammation.

Authors:  Matthias Gaestel; Alexey Kotlyarov; Michael Kracht
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

Review 6.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

Review 7.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

8.  Increased apoptosis and browning of TAK1-deficient adipocytes protects against obesity.

Authors:  Antonia Sassmann-Schweda; Pratibha Singh; Cong Tang; Astrid Wietelmann; Nina Wettschureck; Stefan Offermanns
Journal:  JCI Insight       Date:  2016-05-19

9.  c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis.

Authors:  Xuehua Piao; Sachiko Komazawa-Sakon; Takashi Nishina; Masato Koike; Jiang-Hu Piao; Hanno Ehlken; Hidetake Kurihara; Mutsuko Hara; Nico Van Rooijen; Günther Schütz; Masaki Ohmuraya; Yasuo Uchiyama; Hideo Yagita; Ko Okumura; You-Wen He; Hiroyasu Nakano
Journal:  Sci Signal       Date:  2012-12-18       Impact factor: 8.192

10.  Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.

Authors:  Sayaka Inokuchi; Tomonori Aoyama; Kouichi Miura; Christoph H Osterreicher; Yuzo Kodama; Katsumi Miyai; Shizuo Akira; David A Brenner; Ekihiro Seki
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.